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Abstract 
The assessment of aquatic toxicity and bioaccumulation are important components of the environmental hazard and risk 
assessment of all types of chemicals and are therefore included in several pieces of European Union and international 
legislation. In this document, the European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) 
outlines approaches which will deliver an impact on the replacement, reduction and refinement (3Rs) of fish tests used for 
aquatic toxicity and bioaccumulation testing. The document is based on an assessment of the regulatory needs for these 
endpoints, the scientific state-of-the art and recent activities in these areas. It highlights ongoing efforts at research, 
validation, guideline development and regulatory level. The proposed strategy is also intended to provide a framework for 
the prioritisation of alternative test methods submitted to EURL ECVAM for validation. Implementation of the strategy will 
rely on the coordinated efforts of multiple stakeholders. 
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 Executive summary 
The assessment of aquatic toxicity and bioaccumulation are important components of the 
environmental hazard and risk assessment of all types of chemicals and are therefore 
included in several pieces of European Union (EU) and international legislation. Aquatic 
toxicity refers to the effects of chemicals on organisms living in the water and is usually 
determined by testing on organisms representing the three trophic levels, i.e. plants (or 
algae), invertebrates (crustaceans) and vertebrates (fish). Information on bioaccumulation 
in aquatic organisms is important for understanding the behaviour of a compound in the 
environment. 
Whereas acute aquatic toxicity testing is a basic requirement in most pieces of EU 
chemicals legislation, chronic aquatic toxicity data may be required when the outcome of 
the acute testing indicates a risk or when long term exposure is expected. In addition, 
experimental determination of bioaccumulation may not be necessary if it can be deduced 
by other means (e.g. consideration of physicochemical properties) that a chemical has a low 
potential to bioaccumulate. 
In this document, the European Union Reference Laboratory for Alternatives to Animal 
Testing (EURL ECVAM) outlines a strategy based on approaches which will deliver an impact 
on the replacement, reduction and refinement (3Rs) of fish tests used in the assessment of 
aquatic toxicity and bioaccumulation. The strategy is based on an assessment of the 
regulatory needs for these endpoints, the scientific state-of-the art and recent activities in 
these areas. It is also intended to provide a framework for the prioritisation of alternative 
test methods submitted to EURL ECVAM for validation. 
With regard to aquatic toxicity, the strategy proposes the further development of 
mechanistically-based replacement alternatives for acute and chronic fish toxicity, as well 
as the need to revise existing test guidelines to reduce and refine fish testing, Furthermore, 
the development of guidance on the application of integrated approaches is recommended. 
This includes the use of data-driven approaches such as interspecies extrapolations, acute-
to-chronic relationships and the threshold of toxicological concern approach. 
Concerning bioaccumulation, efforts are encouraged for the development and application of 
in silico models such as quantitative structure-activity relationships and physiologically 
based toxicokinetic models, as well as the standardisation of in vitro methods for hepatic 
metabolism in fish. 
EURL ECVAM is focusing its own in-house activities on promoting the use of available 
alternative methods for fish acute toxicity testing, on exploring the usefulness of scientific 
approaches to support the waiving of chronic fish tests, and on supporting activities at 
OECD level.  
The achievement of the objectives in pursuit of the strategic aims presented here will 
depend on the proactive and coordinated engagement of multiple stakeholders. 
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1. Introduction 
The assessment of aquatic toxicity and bioaccumulation are important components of the 
environmental hazard and risk assessment of all types of chemicals, and are therefore 
included in several pieces of EU chemicals legislation. These include the Regulation 
concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH; 
EC, 2006), the Biocidal Products Regulation (EU, 2012a), the Plant Protection Products 
Regulation (EC, 2009a) and data requirements (EU, 2013a & b), pharmaceuticals (EMA, 
2004; EMA, 2006), feed additives (EC, 2008a; EFSA, 2008) and others. In addition, the 
Cosmetics Regulation (EC, 2009b) states that environmental concerns of cosmetic 
ingredients and products should be addressed through REACH. Information requirements 
according to the different regulations are summarised in Annex I.  
Aquatic toxicity refers to the effects of chemicals on organisms living in the water and is 
usually determined by testing on organisms representing the three trophic levels, i.e. plants 
(or algae), invertebrates (crustaceans such as Daphnia spp.) and vertebrates (fish). 
Information on accumulation in aquatic organisms is important for understanding the 
behaviour of a compound in the environment. The information on aquatic toxicity and 
bioaccumulation may be used for classification and labelling (EC, 2008b), the derivation of 
Predicted No Effect Concentration (PNEC) values for use in risk assessment, and for the 
assessment of PBT substances. In general, the lowest of the available toxicity values (50% 
effective concentration [EC50] or 50% lethal concentration [LC50]) for acute aquatic toxicity; 
x% effective concentration [ECx], Lowest Observed Effect Concentration [LOEC], No 
Observed Effect Concentration [NOEC] for chronic aquatic toxicity) of the different trophic 
levels (fish, crustacean, algae or aquatic plants) are used to define the hazard category, 
derive the PNEC or "Toxicity" criterion. Fish is the preferred species for bioaccumulation 
testing and derivation of a bioconcentration factor (BCF), although data from tests using 
invertebrates or reliable BCF prediction models can be used. 
Whereas acute aquatic toxicity testing is a basic requirement in most pieces of EU 
chemicals legislation, chronic aquatic toxicity testing may be required when the outcome of 
the acute testing indicates a risk, or in the case that long term exposure is expected. 
Moreover, experimental determination of bioaccumulation may not be necessary if it can be 
demonstrated that a chemical has a low potential to bioaccumulate, by using 
physicochemical properties (e.g. log KOW < 3) or other evidence. 
In the light of the EU Directive on the protection of animals used for scientific purposes (EU, 
2010), the EURL ECVAM strategy aims to significantly reduce the overall reliance on animal 
testing. Vertebrate animals used for testing environmental hazard and risk assessment are 
fish, amphibians, birds and, on rare occasions, mammals. A recent paper of Scholz et al. 
(2013) summarises possibilities to reduce the use of vertebrates in environmental risk 
assessment covering aquatic toxicity, avian toxicity, bioaccumulation and endocrine activity. 
The EURL ECVAM strategy described here is narrower in scope, focusing specifically on the 
use of fish for aquatic toxicity and bioaccumulation testing, i.e. does not cover avian 
toxicity, use of fish for testing of endocrine activity and nanomaterials. It is based on an 
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analysis of ongoing international efforts in the research and regulatory domains, including 
method development and validation, test guideline development and regulatory acceptance 
of alternative approaches. Implementation of the EURL ECVAM strategy will rely on the 
coordinated efforts of multiple stakeholders.  
 
2. Background information on fish testing and mechanisms of 
aquatic toxicity 
2.1 Current fish tests 
The OECD Test Guidelines (TGs) and EU test methods for acute and chronic fish toxicity 
involve the use of fish at various life stages, e.g. early life stages, juvenile or adult fish 
(Annex II).  
The fish acute toxicity test (OECD TG 203; OECD, 1992) is a short-term exposure test (96 h) 
and determines the concentration that is lethal to 50% of the fish (LC50).  
The fish early life-stage toxicity test (FELS; OECD TG 210; OECD, 2013a) is the most 
commonly used test to establish chronic fish toxicity, i.e. to determine lethal and sublethal 
effects of a chemical on early life stages of fish (embryos, larvae, juvenile fish). The 
endpoints are hatching success, abnormal appearance, abnormal behaviour, survival or 
mortality, and the weight and length of the fish at the end of the test. By comparison to the 
values of control fish, the LOEC, NOEC and/or ECx are determined for each endpoint.  
Two further OECD TGs are available for chronic fish toxicity testing, however, they cover 
fewer developmental stages and are less frequently used: OECD TG 212 (Fish, Short-term 
Toxicity Tests on Embryo and Sac-fry Stages¸ OECD 1998) uses fish embryos and sac-fry 
stages; OECD TG 215 (Fish, Juvenile Growth Test; OECD, 2000) assesses the effects of a 
chemical on the growth of juvenile fish for 28 days. Some regulatory frameworks 
recommend the use of OECD TG 212 and OECD TG 215, if it is not possible to carry out an 
OECD TG 210. For plant protection products (EU, 2013a & b), a fish full life-cycle test (US 
EPA, 1996) may be required. 
 
2.2 Mechanistic understanding of aquatic toxicity 
A number of modes of action that can lead to (acute) aquatic toxicity have been defined 
and associated with chemical classes. For example, Verhaar et al. (1992) proposed four 
aquatic Modes of Action (MOA) and assigned them to four classes (Verhaar Class 1-4): 
MOA1 for chemicals acting by nonpolar narcosis (or baseline toxicity); MOA2 for chemicals 
acting by polar narcosis (including [substituted] phenols and [substituted] anilines); MOA3 
for chemicals with non-specific reactivity (including aldehydes and epoxides); and MOA4 for 
chemicals with specific reactivity (including pesticides, polychlorinated biphenyls and some 
polycyclic aromatic hydrocarbon metabolites). Later, a fifth class was defined for chemicals 
not covered by MOAs 1-4 (Enoch et al., 2008).  
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Russom et al. (1997) extended the Verhaar classification scheme and distinguished eight 
modes of action (base-line narcosis or narcosis I, polar narcosis or narcosis II, ester narcosis 
or narcosis III, oxidative phosphorylation uncoupling, respiratory inhibition, 
electrophile/proelectrophile reactivity, acetylcholinesterase inhibition, and central nervous 
system seizure). These structure-based schemes for MOA classification have informed the 
development of Quantitative Structure-Activity Relationship (QSAR) models and the 
application of read-across.  
More recently, Ankley et al. (2010) discussed how mechanistic considerations could 
advance ecological risk assessment and proposed the Adverse Outcome Pathway (AOP) as 
"a conceptual construct that portrays existing knowledge concerning the linkage between a 
direct molecular initiating event and an adverse outcome at a biological level of 
organisation relevant to risk assessment", e.g. survival, development, and reproduction at 
the population level for ecology. AOPs could be applied to focus toxicity testing in terms of 
species and endpoint selection, extrapolation between chemicals, the prediction of mixture 
effects (Ankley et al., 2010) and the development of Integrated Approaches to Testing and 
Assessment (IATA) and the building of chemical categories (Schultz, 2010).  
To coordinate and harmonise various international efforts in AOP development, the OECD 
launched the AOP Development Programme in January 2013. This programme is managed 
by the Extended Advisory Group on Molecular Screening and Toxicogenomics that the 
European Commission (Joint Research Centre - EURL ECVAM) is co-chairing together with 
the US Environmental Protection Agency (US EPA). In this context an AOP Knowledge Base 
(AOP KB) is currently being developed within a multi-partner collaborative project led by 
EURL ECVAM and the US EPA to facilitate the contribution to, and evaluation of, current 
pathway information collected by a wide range of experts. The first AOP KB module, the 
AOP wiki, is publicly accessible online (https://aopkb.org/). 
 
3. Background information on fish bioaccumulation testing  
Assessing whether a chemical accumulates in aquatic organisms is important for 
understanding its behaviour in the environment. Bioconcentration describes the 
accumulation of a water-borne chemical by an aquatic organism, whereas bioaccumulation 
covers the uptake from all environmental sources, e.g. water, food and sediment. The 
bioconcentration potential of a chemical, expressed as the 'BCF', is either predicted or 
measured (typically in fish, but if necessary, also in invertebrates). The BCF describes the 
ratio of the concentration of a chemical in the whole organism to its concentration in the 
water, under equilibrium conditions.  
Accumulation of a chemical in an organism is the result of several physiological processes, 
namely Absorption, Distribution, Metabolism, and Excretion (ADME). Apart from excretion via 
fish gills and intestine, metabolism (biotransformation) plays an important role in the 
elimination (depuration) of a chemical from the fish organism.  
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OECD TG 305 (Bioaccumulation in Fish: Aqueous and Dietary Exposure; OECD, 2012a) 
includes two exposure routes, namely, aqueous and dietary. The aqueous exposure setup 
determines the BCF. In general, two concentrations, a water and, if necessary, a solvent 
control are required and fish are sampled at various time points (five during the uptake 
phase and four during the depuration phase). For non-polar organic chemicals, OECD TG 
305 allows several exposure scenarios; for example, the test is conducted only at one 
concentration and/or the sampling steps are reduced to four. These simplified testing 
schemes have the potential to reduce the overall number of fish used (i.e. at least 108 fish 
are used for a full test). Creton et al. (2013) showed in their analysis of BCF values of 55 
plant protection products that there was no statistically significant difference in the BCF 
values derived with low and high concentrations, and concluded that testing at one 
concentration would be sufficient.  
As stated in the OECD TG 305, a dietary magnification factor is determined with the dietary 
exposure route, which should be used for strongly hydrophobic substances (log KOW > 5 and 
solubility below 0.01-0.1 mg/L) where the aqueous exposure methodology is not 
practicable. The test consists of two phases: uptake (test substance-spiked feed) and 
depuration (clean, untreated feed). Depending on the test design and sampling scheme, at 
least 50-120 fish for chemical exposure, 50-110 control fish, and, if needed 15 fish for 
lipid correction, are used. 
Over the last decade, several strategies for fish bioaccumulation testing (or waiving) have 
been published taking into account existing information, non-testing methods (in silico, 
read-across, weight-of-evidence), and testing methods (biomimetic techniques, in vitro 
methods, reduced fish bioconcentration tests, use of other aquatic species as invertebrates) 
when deciding on the bioaccumulative potential of a chemical (de Wolf et al., 2007; Grindon 
et al., 2008; ECHA, 2012a; Lombardo et al., 2014). The further development of these 
strategies should consider recent advances in the development of physiologically-based 
toxicokinetic (PBTK) models (see Section 4) that can be used to predict bioaccumulation and 
toxicologically relevant internal concentrations in test animals (e.g. fish) following defined 
exposure scenarios.  
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4. Proposed strategy to replace, reduce and refine the use of fish in 
aquatic toxicity and bioaccumulation testing 
Taking into account the current state-of-the-art, EURL ECVAM proposes that efforts should 
be directed towards the identification and classification of acute and chronic fish toxicity as 
well as bioaccumulation using a variety of approaches that minimise or preferably avoid 
the use of animals. To achieve this goal, the following three key aims should be pursued:  
Strategic Aim 1:  Replacement and reduction of the need of fish for aquatic 
toxicity testing 
Strategic Aim 2: Replacement and reduction of the need of fish for 
bioaccumulation testing 
Strategic Aim 3:  Reduction and refinement of current fish tests  
The objectives and related activities to achieve these aims are summarised in Figure 1 and 
are described below. Although different approaches will be more applicable in different 
sectors, their collective realisation is expected to have a significant impact on regulatory 
testing while ensuring an effective level of protection of the environment.  
 
 
Figure 1: Summary of EURL ECVAM strategy to replace, reduce and refine the use of fish in 
aquatic toxicity and bioaccumulation testing   
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4.1 Strategic Aim 1: Replacement and reduction of the use of fish in aquatic 
toxicity testing 
Objective 1.1:  Explore the use of fish cell line-based assays for fish toxicity 
testing 
A vast number of fish cell lines have been established covering a wide range of fish species 
and tissues. For the purpose of toxicity testing, cell lines deriving from gills or liver are 
playing an important role, i.e. gills are the primary target and uptake site of aquatic 
contaminants and are involved in gas exchange, osmoregulation and other critical functions 
(Lee et al., 2009), while the liver has a high metabolic capacity and detoxification function 
(Lee et al., 1993; Schirmer, 2006). For many years, fish cell line-based assays have been 
proposed as alternatives to fish in aquatic toxicity testing (reviewed by e.g. Castaño et al., 
2003; Bols et al., 2005; Schirmer, 2006). More recently, they have also been proposed as 
tools to explore toxicity pathways at the molecular and cellular levels (Ankley et al., 2010; 
see below) and to predict internal concentrations in fish by using toxicokinetic models 
(Stadnicka-Michalak et al., 2014). 
A recent project funded by the Cefic Long-range Research Initiative (CEFIC-LRI; ECO8 - 
CEllSens project; http://www.cefic-lri.org/projects) aimed at the standardisation of a 
cytotoxicity assay using the rainbow trout gill cell line (RTgill-W1). Tanneberger et al. (2013) 
tested 35 organic chemicals with the standardised assay and recommended its use for 
acute fish toxicity testing. Further evaluation of its reproducibility, predictive capacity and 
applicability domain is however needed. As a follow-up of the CEllSens project, a ring trial 
was launched in 2014 under the lead of the Swiss Federal Institute of Aquatic Science and 
Technology (K. Schirmer), which aims at assessing the transferability and reproducibility of 
the assay with a restricted number of chemicals. Following the pre-submission of the 
RTgill-W1 cytotoxicity assay in early 2014, EURL ECVAM has invited the test submitter to 
provide a full test submission.  
 
Objective 1.2: Promote the use of the zebrafish embryo acute toxicity test as 
an alternative to the acute fish toxicity test  
The zebrafish embryo acute toxicity test (ZFET) is based on the use of newly fertilised eggs 
from zebrafish (Danio rerio). It is a short-term exposure test (96 h) and determines the 
concentration that is lethal to 50% of the zebrafish embryos (LC50). Observation of one of 
the following apical endpoints indicates the death of the embryo: coagulation of the 
embryo, lack of somite formation, non-detachment of the tail and lack of heartbeat. EURL 
ECVAM contributed to the validation of the ZFET and the subsequent development of the 
recently published OECD TG 236 "Fish embryo acute toxicity test" (OECD, 2013b), both as a 
member of the relevant OECD expert group and as the coordinator of the OECD validation 
study (OECD, 2011; 2012b, Busquet et al., 2014). 
The EURL ECVAM Recommendation on the ZFET was published in July 2014 after 
consultation with regulators, stakeholders and the public (EURL ECVAM, 2014). It concludes 
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that the ZFET is transferable and reproducible within and between laboratories as shown in 
the OECD validation study. The comparison of data on 144 chemicals (Belanger et al., 
2013) demonstrated a strong correlation (r = 0.9) between fish embryo acute toxicity data 
(24-120 h exposure; mainly zebrafish) and fish acute toxicity data (96 h; five freshwater 
species recommended in OECD TG 203). Notably, the chemicals covered a broad range of 
physicochemical properties, toxicological modes of action, and sectorial use, e.g. industrial 
chemicals (77), plant protection products (21), biocides (5), and pharmaceuticals (8). The 
EURL ECVAM Recommendation concluded therefore that the ZFET provides information on 
acute fish toxicity that can be considered comparable to that derived from standard acute 
fish toxicity tests (e.g. OECD TG 203; OECD 1992) and thus it should be seriously 
considered for deriving information of acute fish toxicity whenever possible.  
The use of the ZFET will result in an overall refinement and reduction of tests on juvenile 
and adult fish required for aquatic toxicity testing. Within the provisions of the Directive 
2010/63/EU on the protection of animals used for scientific purposes (EU, 2010), the 
embryos used in the ZFET should not be considered as "independently feeding larval forms" 
and therefore the procedure, as far as the embryos are concerned, does not fall within its 
scope. Moreover, the Commission Implementing Decision 2012/707/EU (EU, 2012b) on a 
common format on collection of information on the use of animals for scientific purposes 
in the EU Member States instructs that Fish should be counted from the stage of being 
capable of independent feeding onward. Zebrafish kept in optimal breeding conditions 
(approximately + 28°C) should be counted 5 days post fertilisation. 
The EURL ECVAM Recommendation underlines that OECD TG 236 should be used for 
generating information on acute fish toxicity where appropriate and, accordingly, be 
included into the respective pieces of legislation and guidance documents. If deemed 
necessary, an OECD guidance document on the use of OECD TG 236 across the various 
regulatory frameworks could be developed addressing in particular its use to generate 
information on acute fish toxicity and its limitations.  
The database containing fish embryo acute toxicity data and fish acute toxicity data 
(Belanger et al., 2013) should be maintained and updated on a regular basis. This would 
provide additional insight into the practical use of the ZFET and enhance confidence in the 
applicability domain. As noted by Belanger et al. (2013), it was not possible to find acute 
fish toxicity data for all chemicals for which fish embryo toxicity data were available. For 
example, acute fish data could be retrieved for only eight out of the 22 pharmaceuticals 
tested. Therefore, industry and regulatory bodies are encouraged to make existing data 
available where possible. This would also be a valuable resource for the development of 
QSARs and AOPs. 
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Objective 1.3: Promote the use of the threshold approach for acute fish toxicity 
testing  
The Threshold Approach for Acute Fish Toxicity Testing is a tiered testing strategy which 
has the potential to significantly reduce the number of fish used for acute aquatic toxicity 
testing. It is based on the fact that the LC50/EC50 value of the most sensitive of the three 
test species (fish, algae and invertebrates) is commonly used for hazard and risk 
assessment and that fish is often not the most sensitive test species. This concept was first 
described for pharmaceuticals as a "threshold/step-down" approach by Hutchinson et al. 
(2003) and further developed for chemicals by the Joint Research Centre (JRC) (Jeram et 
al., 2005; ECVAM, 2006). 
The OECD Guidance Document (GD) 126 "Short guidance on the use of the threshold 
approach for acute fish toxicity testing" has been available since 2010 (OECD, 2010). In 
brief, an acute fish test (following the limit test as given in OECD TG 203) is performed at a 
single concentration (threshold concentration) corresponding to the lowest LC50/EC50 value 
derived with daphnids or algae. If no mortality occurs at the threshold concentration, it is 
concluded that fish are not the most sensitive of the three species and toxicity to fish is 
reported as greater than the threshold concentration. If mortality occurs, a full OECD TG 
203 study is needed. 
The threshold approach has been incorporated into various testing strategies and guidance 
documents, e.g. the REACH guidance on information requirements and chemical safety 
assessment (Chapter R.7b: Endpoint specific guidance; ECHA, 2012b) and the OECD Fish 
Toxicity Testing Framework (OECD, 2012c). It is further mentioned as a preferred method 
for deriving data on acute fish toxicity in the biocidal products regulation (EU, 2012a) and 
in the Commission regulations on data requirements for plant protection products (2013a 
& b). The use of the threshold approach in other areas where acute fish toxicity data may 
be specifically required, e.g. veterinary pharmaceuticals and feed additives, should be 
explored.  
 
Objective 1.4: Applying the Adverse Outcome Pathway (AOP) concept  
The paper of Ankley et al. (2010) triggered many activities focusing on the development of 
AOPs for environmental toxicity. For example, two workshops organised by the "Animal 
Alternatives in Environmental Risk Assessment Technical Committee" of the International 
Life Sciences Institute's Health and Environmental Sciences Institute (ILSI HESI) specifically 
addressed AOPs relevant for chronic fish toxicity and how they could be discovered and 
annotated (Volz et al., 2011; Villeneuve et al., 2014).  
In 2013, the CEFIC LRI-funded project (LRI-ECO20-UA) Development of an alternative 
testing strategy for the fish early life-stage test for predicting chronic toxicity started. It 
aims to map FELS-relevant AOPs, develop an in vitro toolbox for screening FELS-relevant 
AOPs (Tier 1) and zebrafish embryo based assays (Tier 2). 
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At the recent workshop on "Advancing Adverse Outcome Pathways for Integrated Toxicology 
and Regulatory Applications" (March 2014; Somma Lombardo Italy; co-organised by 
Environment Canada, US EPA, US ERDA, JRC, as well as academic institutes/organisation 
from USA, Switzerland, and Norway), one working group specifically addressed AOPs and 
their use in chronic toxicity testing for environmental hazard and risk assessment. The 
outcome of the discussions is presented in two papers, one addressing the challenges and 
research needs (Groh et al., 2014a) and the other focusing on possible AOPs for fish growth 
impairment (Groh et al., 2014b).  
The increasing availability of AOPs for aquatic toxicity endpoints should be used to inform 
the development of IATA that will serve to replace and reduce the use of fish.  
 
Objective 1.5: Evaluate possibilities for supporting the waiving of chronic fish 
toxicity tests  
Several research groups are working on data-driven approaches, such as those described 
below, to develop a sound scientific basis to justify the waiving of animal tests.  
1.5.1: Use of Quantitative Structure-Activity Relationships 
There is an extensive literature on QSARs for fish toxicity, and in particular acute fish 
toxicity, (Netzeva et al., 2007; 2008; Brooke et al., 2006a; Brooke et al., 2006b; EFSA, 
2013). Many of these studies have focused on the development of QSARs for specific 
modes of action, including polar narcosis, non-polar narcosis, reactivity-based toxicity, and 
specifically acting mechanisms (involving non-covalent interactions with receptors or 
enzymes or endocrine active chemicals [e.g. Jacobs, 2004]).  
Recently, several QSARs have been developed for chronic fish toxicity (de Haas et al., 2011; 
Claeys et al., 2013; Austin and Eadsforth, 2014) mainly addressing chemicals acting via 
narcosis. The development of mechanistically based QSARs for fish toxicity with a view to 
their potential use in supporting the waiving of chronic fish testing should be supported. 
1.5.2: Extrapolating across species and from acute to chronic effects  
Regulatory aquatic risk assessment schemes require toxicity testing of chemicals on a 
limited number of laboratory species; thus, extrapolation from the obtained toxic responses 
to all species representing that trophic level in the environment is a fundamental tenet of 
regulatory ecotoxicological risk assessment. To derive the PNEC for aquatic toxicity, safety 
factors are applied to the laboratory data. These factors are intended to account for 
interspecies differences in sensitivity, extrapolation from acute to chronic effects, the 
physicochemical complexity of natural water versus laboratory test media, and the 
complexity of the ecosystem versus single species laboratory tests. The choice of the factor 
(10, 100 or 1000) depends on the quality and quantity of the available data.  
Differences in species sensitivity to acute aquatic toxicity have been well described (Weyers 
et al., 2000; Hutchinson et al., 2003, Jeram et al., 2005; Hoekzema et al., 2006; Tebby et 
al., 2011). To address the question of whether it is possible to predict acute toxicity in fish 
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from non-vertebrate species, Netzeva et al. (2007) reviewed several Quantitative Activity-
Activity Relationships between species, the most relevant and reliable relationship for acute 
fish toxicity being between Daphnia (D.) magna and rainbow trout (n=360), with an r2 value 
of 0.67. More recent studies have confirmed the good correlation between acute fish and 
daphnia toxicity data, especially for organothiophosphates (0.74<r2<0.94) and 
(benzo)triazoles (r2=0.87) (Zvinavashe et al., 2009; Kar et al., 2010; Zhang et al., 2010; 
Cassani et al., 2013). The correlation depends on both the bio-uptake process and the MOA 
of the chemical (Zhang et al., 2010), as well as its physicochemical properties (Tebby et al., 
2011).  
The US EPA has developed the Interspecies Correlation Estimation (ICE) tool (implemented 
as WebICE; Raimondo et al., 2010) to predict acute toxicity to three relevant fish species 
(fathead minnow, rainbow trout, and common carp) on the basis of D. magna toxicity, with 
the strongest correlation being evident between D. magna and rainbow trout (r2=0.51). 
EURL ECVAM is currently exploring whether interspecies extrapolations and acute-to-chronic 
relationships can be used for supporting the waiving of chronic fish tests. For this purpose, 
data (LC50, NOEC) for D. magna and fish have been extracted from various databases and 
analysed to identify possible relationships taking into consideration different MOAs 
(intended for publication). 
1.5.3: Threshold of Toxicological Concern in aquatic toxicity assessment 
The Threshold of Toxicological Concern (TTC) approach is based on the premise that there is 
a general exposure limit for chemicals below which no significant risk to human health or 
the environment is expected. The potential application of the TTC approach in aquatic 
toxicity assessment has been explored by de Wolf et al. (2005) who collated reliable acute 
and chronic aquatic toxicity data from several ecotoxicity databases and derived an aquatic 
exposure threshold of no concern (ETNCaq) of 0.1 µg/L for chemicals with MOA1-3 according 
to the Verhaar scheme. Tolls et al. (2009) proposed using this approach for environmental 
risk assessment of poorly water soluble ingredients (e.g. as long-chain fatty alcohols, 
esters, and ethers) of personal care products. They set the ETNCaq of 1.9 µg/L calculated by 
de Wolf et al. (2005) for chemicals with MOA 1-2 as a limit for water solubility. If the water 
solubility of a chemical is less than 1.9 µg/L, the aquatic exposure level would not exceed 
the ecotoxicological no-effect concentration level and thus further testing would not be 
necessary.  
The ILSI HESI "Animal Alternatives in Environmental Risk Assessment Project Committee" is 
currently exploring in collaboration with international partners the applicability and 
usefulness of the TTC approach for ecotoxicity assessment in view of its potential to reduce 
testing on vertebrate organisms. 
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4.2 Strategic Aim 2: Replacement and reduction of the use of fish in 
bioaccumulation testing 
Objective 2.1: Explore the use of toxicokinetic models to predict 
bioaccumulation  
As for the prediction of acute and chronic fish toxicity, there is ongoing research into 
toxicokinetic models using data derived from a combination of fish cell line based assays 
(Stadnicka-Michalak, presentation at SETAC EU 2014) or fish embryos (Kühnert et al., 2013) 
to predict bioaccumulation. However, more research and application experience are 
necessary before these approaches may be deployable in a broader regulatory context. 
Nichols et al. (2013) developed two toxicokinetic models to predict the bioconcentration of 
well-metabolised chemicals in rainbow trout. Both are 1-compartment models and the 
whole body biotransformation rate is extrapolated from in vitro intrinsic clearance rates 
derived with S9 trout liver fraction or trout hepatocytes (see below). Laue et al. (2014) used 
several models including the S9 BCF model of Nichols et al. (2013) to predict the BCF 
values of nine fragrances ingredients and compared them to measured fish BCF values. 
This comparison showed that the S9 BCF model (with no correction for potential binding 
effects on hepatic clearance) provided the most accurate predictions of measured BCFs; i.e. 
correctly identified the two bioaccumulative and the nine non-bioaccumulative chemicals.   
 
Objective 2.2: Improvement of QSAR models for BCF prediction 
QSAR models based on log KOW are widely used to screen chemicals for potential 
bioaccumulative properties and predict BCFs (reviewed by Pavan et al., 2008). These are 
mostly linear regression models that do not account for ADME processes. By neglecting the 
contribution of metabolism as a clearance mechanism, these models might overestimate 
the bioaccumulative potential of a chemical and consequently trigger unnecessary in vivo 
tests. 
More recent research has focused on the development of QSAR models which include 
metabolism/biotransformation as a contributing factor (Dimitrov et al., 2005). Arnot et al. 
(2009) developed a QSAR model which predicts metabolic biotransformation rates based 
on chemical structure. This model is part of the BCF/BAFTM programme of the US EPA 
Episuite software (US EPA, 2012).  
Other authors proposed the use of in vitro metabolic transformation rates to refine BCF 
models and make them more reliable (Han et al., 2007; Han et al., 2009; Crowan-Ellsberry 
et al., 2008; Dyer et al., 2008; Gomez et al., 2010; Nichols et al., 2013).  
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Objective 2.3: Development of an OECD test guideline "In vitro fish hepatic 
metabolism"  
In April 2014, the OECD Working Group of National Coordinators for the OECD Test 
Guideline Program (WNT) approved a project (under the lead of USA and European 
Commission represented by JRC - EURL ECVAM) on the development of a new OECD TG on 
In vitro Fish Hepatic Metabolism. The project aims at standardising two in vitro methods 
using rainbow trout S9 fraction (Johanning et al., 2012) or cryopreserved rainbow trout 
hepatocytes (Fay et al., 2014) to determine in vitro fish intrinsic hepatic clearance rates. A 
multi-laboratory ring trial to assess the reliability, transferability, and predictive value of 
the two in vitro systems started in late 2014 and will provide results in 2015. It builds on 
work carried out within the framework of the ILSI HESI project "Bioaccumulation", which will 
coordinate the ring trial. The outcome will serve as basis for developing the OECD TG. 
Other methods for deriving information on in vitro fish metabolism could be based on the 
use of the fish liver cell line RTL-W1 (Lee et al., 1993) or the 3D cultures of trout 
hepatocytes (Baron et al., 2012).  
 
4.3 Strategic Aim 3: Reduction and refinement of current fish tests  
Objective 3.1: Revision of OECD TG 203 Fish Acute Toxicity  
OECD TG 203 is one of the few regulatory required tests using death as an endpoint, which 
according to Directive 2010/63/EU (Article 13; EU, 2010) should be avoided whenever 
possible in favour of humane endpoints based on clinical signs. 
Switzerland and the UK have initiated an OECD project on the revision of OECD TG 203 
aiming at reduction and refinement. The project follows up recommendations of the OECD 
Fish Toxicity Testing Framework (OECD, 2012c) and is based on the work of Rufli and 
Springer (2011) and Rufli (2012). The first draft of the revised guideline became available 
in September 2014 on the OECD website. It proposes that the number of fish per 
concentration should be reduced from seven to six and that humane endpoints should be 
applied, i.e. fish showing severe clinical signs as abnormalities in swimming behaviour, 
equilibrium, respiration, pigmentation, should be humanely killed.  
 
Objective 3.2: Revision or deletion of OECD TG 212 Short-term Toxicity Tests on 
Embryo and Sac-fry Stages 
The OECD Fish Toxicity Testing Framework (OECD, 2012c) recommends the deletion of 
OECD TG 212 due not only to scientific and animal welfare concerns, but also a lack of 
regulatory relevance. In Europe, only the REACH legislation refers to OECD TG 212 as a 
possible test for chronic fish toxicity. According to OECD TG 212, exposure starts with 
fertilised eggs and should be terminated before the yolk-sac is completely absorbed or 
before mortality due to starvation of the fish embryos begins. The guideline includes 
recommendations on the duration of the test, which varies depending on the species used. 
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However, nowadays it is well known that fish embryos may depend on external food supply 
and start feeding even before the yolk-sac is absorbed. For example, zebrafish embryos 
start feeding around 48h after hatch and would starve without external food supply if kept 
for the recommended 8-10 days.  
The recommendation of OECD Fish Toxicity Testing Framework (OECD 2012c) should be 
followed up at OECD level, either by deleting OECD TG 212 or by revising it in the light of 
its potential use and taking into account animal welfare concerns. 
 
Objective 3.3: Development of an OECD guidance document on OECD TG 305  
As mentioned above, OECD TG 305 "Bioaccumulation in Fish: Aqueous and Dietary 
Exposure" (OECD, 2012a) has recently been revised and now includes two exposure routes - 
aqueous and dietary. For non-polar organic chemicals, OECD TG 305 allows various 
exposure scenarios; for example, the test is conducted only at one concentration and/or the 
sampling steps are reduced to four. Both approaches use significantly fewer fish than a full 
aqueous or dietary study.  
Germany, the Netherlands, and the United Kingdom are leading an OECD project aiming at 
the development of an OECD guidance document on OECD TG 305. Among other aspects, 
this document should include detailed guidance on the use of the minimised aqueous 
approaches. 
 
Objective 3.4: Reduction of control animals in fish tests 
The OECD Fish Toxicity Testing Framework (OECD, 2012c) states that there is a need to 
consider whether both water and solvent controls are needed when a solvent is used. At 
present this is a requirement for various fish tests. Following up discussions initiated by the 
International Council on Animal Protection in OECD Programmes (ICAPO) at the 25th WNT 
meeting in 2013, the European Commission (JRC - EURL ECVAM) and ICAPO have submitted 
a project proposal to OECD which aims at reviewing historical data and the relevance of 
running two controls. 
 
5. Indicative timelines 
An indication of the timelines related to the achievement of the aims and objectives 
underpinning the proposed strategy are provided in Figure 2. It should be noted that these 
are simply estimates of what EURL ECVAM believes might be possible with the concerted 
and coordinated effort of all stakeholders and the availability of sufficient resources.  
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Figure 2: Indicative timelines of the EURL ECVAM strategy assuming the concerted and 
coordinated effort of all stakeholders and the availability of sufficient resources. 
 
6. Conclusions 
This document presents the EURL ECVAM strategy for achieving significant 3Rs impact in 
the areas of aquatic toxicity and bioaccumulation. The aims and objectives of the strategy 
are underpinned by a number of activities that have been identified and involve a variety of 
actors. Successful implementation of the strategy will deliver alternative approaches that 
address standard information requirements in many sectors while ensuring that animal 
testing is only conducted as a last resort. One important near-term impact could be the 
reduction of animal testing necessary for the implementation of REACH and the 2018 
registration deadline. 
EURL ECVAM is focusing its current in-house activities on promoting the use of available 
alternative methods for fish acute toxicity testing, on exploring the usefulness of scientific 
approaches (e.g. acute-to-chronic relationships) to facilitate the waiving of chronic fish 
tests, and on supporting activities at OECD level. However, the intention is continually 
review the EURL ECVAM work programme as the implementation of the overall strategy 
progresses and in order to complement the work of important European and international 
actors. EURL ECVAM will also continue evaluating alternative test methods submitted for 
validation in light of their potential value to contribute to aspects of this strategy.   
The ultimate achievement of the aims and objectives comprising this strategy will depend 
on the proactive and coordinated engagement of multiple stakeholders.  
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Annex I. EU regulatory information requirements for fish toxicity and bioaccumulation 
 
Regulatory framework 
Endpoint 
Short-term fish toxicity Long-term fish toxicity Bioaccumulation 
Industrial chemicals (REACH) 
Regulation (EC) No. 1907/2006  
(EC, 2006) 
> 10t/year (Annex VIII) 
Not to be conducted if: 
- aquatic toxicity is unlikely to occur, 
e.g. chemical highly insoluble in water 
or unlikely to cross biological 
membranes or 
- a long-term aquatic toxicity study on 
fish is available  
In general applicants are invited to 
consider long-term aquatic toxicity testing:  
- as described in Annex IX  
o shall be considered if the 
chemical safety assessment 
according to Annex I indicates the 
need to investigate further 
effects on aquatic organisms. 
o if the substance is poorly water 
soluble. 
> 100t/year (Annex IX) 
- Long-term toxicity testing shall be 
proposed by the registrant if the 
chemical safety assessment 
according to Annex I indicates the 
need to investigate further the effects 
on aquatic organisms. The choice of 
the appropriate test(s) depends on the 
results of the chemical safety 
assessment. 
 
Appropriate tests:  
- Fish early-life stage (FELS) toxicity 
test (OECD TG 210);  
- Fish short-term toxicity test on 
embryo and sac-fry stages (OECD TG 
212) or  
- Fish, juvenile growth test (OECD TG 
215) 
>1000t/year (Annex X) 
Not to be conducted if: 
- the substance has a low potential for 
bioaccumulation (for instance a log 
KOW ≤ 3) and/or a low 
- potential to cross biological 
membranes, or 
- direct and indirect exposure of the 
aquatic compartment is unlikely. 
Cosmetic ingredients  
Regulation (EC) No 1223/2009  
(EC, 2009b) 
Recital (5): The environmental concerns that substances used in cosmetic products may raise are considered through the application 
of Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the 
Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) and establishing a European Chemicals 
Agency(4) OJ L 396, 30.12.2006, p. 1. (4), which enables the assessment of environmental safety in a cross-sectoral 
manner. 
Plant protection products 
data requirements - active 
substance 
Regulation (EU) No 283/2013 
(EU, 2013a) –  
Active substance: 
Threshold approach or OECD TG 203 
(rainbow trout) 
 
 
Active substance: 
Fish early-life stage (FELS) toxicity test 
(OECD TG 210) 
- if exposure of surface water likely and 
the substance stable in water;  
Fish full life cycle test (USEPA OCSPP 
850.1500) may be required 
Active substance: 
To be conducted if  
- log KOW > 3 or other indications that 
the chemical may bioaccumulate in 
fish,  
- the substance is stable in water 
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Regulatory framework 
Endpoint 
Short-term fish toxicity Long-term fish toxicity Bioaccumulation 
Plant protection products 
data requirements - product 
Regulation (EU) No 284/2013 
(EU, 2013b) 
Product: 
Only if the toxicity cannot be predicted 
from the active substance(s) or read-
across 
 
In case that fish data are needed: 
Threshold approach or OECD TG 203 
(rainbow trout) 
Product: 
Only if the toxicity cannot be predicted 
from the active substance(s) 
 
Necessary studies should be discussed 
with competent authority 
 
 
Biocidal products  
Regulation (EU) No 528/2012 
(EU, 2012a) 
Guidance on data 
requirements (ECHA, 2013) 
 
Only to be carried out if 
exposure is likely.  
 
Note for Products: Testing on the 
product itself only when valida 
data on components are missing 
or synergistic effects to be 
expected  
Active substance: 
Core data set 
Short-term toxicity testing on fish -When 
short-term fish toxicity data is required 
the threshold approach (tiered strategy) 
should be applied.  
 
The study does not need to be conducted 
if a valid long-term aquatic toxicity study 
on fish is available.  
 
 
Active substance: 
Additional data set  
depending on the results of the studies on 
fate/behaviour and intended use, e.g. risk 
to the aquatic environment, and long-term 
exposure:  
- long-term toxicity studies on fish may be 
required, one or two tests, OECD TGs 210, 
212, 215 or fish full life cycle test 
 
Active substance: 
Core data set:  
Estimation methods and experimental 
determination.  
The experimental determination may not 
need to be carried out if:  
- it can be demonstrated on the basis of 
physico-chemical properties (e.g. log KOW < 
3) or other evidence that the substance 
has a low potential for bioconcentration 
 
Additional data set: bioaccumulation in an 
appropriate aquatic species may be 
required 
Veterinary Medicinal 
Products  
Stepwise approach with initial 
screening (Phase I) to identify 
exposure, bioaccumulation, 
persistence. If given then studies 
are performed (Phase II). 
Phase II: CVMP/VICH/790/03-
FINAL; EMEA, 2004) 
(corresponds to VICH GL38) 
Phase II:  
Tier A – aquatic effect study 
- OECD TG 203 
Phase II:  
Tier B - if risk quotient (PECrefined/PNEC) > 1 
for fish, OECD TG 210 - fish early life 
stage test 
Phase II 
Tier B – if log KOW > 4 and evidence for 
bioaccumulation from other studies, OECD 
TG 305 to be carried out 
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Regulatory framework 
Endpoint 
Short-term fish toxicity Long-term fish toxicity Bioaccumulation 
Human Medicinal Products  
Stepwise approach with initial 
screening (Phase I) to identify 
exposure, bioaccumulation, 
persistence. If given then studies 
are performed (Phase II) 
Phase II: CHMP/SWP/4447/00 
(EMA, 2006)  
Not required Phase II: 
Tier A – base set requirement  
OECD TG 210 – fish early life stage test 
Phase II: 
Tier B – depending on information on fate 
in Tier A, bioconcentration study with drug 
substance or its metabolites 
Feed additives  
Regulation (EC) No 429/2008 
(EC, 2008a) & (EFSA, 2008) 
Stepwise approach with initial 
determination (Phase I) whether 
a significant environmental 
effect of the additive is likely 
(based on estimated PEC). If 
likely, then studies are 
performed (Phase II) 
Phase IIa:  
OECD TG 203 
Phase IIb:  
OECD TG 210 
- 
 
CLP Regulation  
Regulation (EC) No 1272/2008 
EC (2008b) 
In the EU, the core classification system for aquatic environmental hazards consists of one acute (Acute 1) and three chronic (Chronic 
1 – 3) hazard classification categories (EC, 2008). If adequate chronic toxicity data are not available, a combination of acute aquatic 
toxicity data and information on the environmental fate (degradability and bioaccumulation) is used to decide on the appropriate 
Chronic category. In addition, a "safety net" classification referred to as category Chronic 4 can be applied for substances which 
cannot be classified in any of the four categories but nevertheless raise some concerns. 
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Annex II. Test Guidelines covering fish toxicity and bioaccumulation 
 
Guideline 
OECD TG 236 – Fish 
Embryo Acute 
Toxicity (FET) Test 
OECD TG 203 – 
Fish, Acute Toxicity 
Test 
OECD TG 210 – 
Fish, Early-life 
Stage Toxicity Test 
(as revised in 2013) 
OECD TG 212 – 
Fish, Short-term 
Toxicity Test on 
Embryo and Sac-
Fry Stages 
OECD TG 215 – 
Fish, Juvenile 
Growth Test 
USEPA OCSPP 
850.1500 – Fish 
life cycle test* 
OECD TG 305 – 
Bioaccumulation in 
Fish 
Species zebrafish (Danio 
rerio); 
 
in development for 
fathead minnow 
zebrafish (Danio 
rerio),  
fathead minnow 
(Pimephales 
promelas),  
Japanese medaka 
(Oryzias latipes), 
rainbow trout 
(Oncorhynchus 
mykiss) 
bluegill sunfish1 
(Lepomis 
macrochirus), 
common carp1 
(Cyprinus carpio), 
guppy1 (Poecilia 
reticulate) 
rainbow trout 
(Oncorhynchus 
mykiss) 
zebrafish (Danio 
rerio),  
fathead minnow 
(Pimephales 
promelas),  
Japanese medaka 
(Oryzias latipes) 
sheepshead minnow2 
(Cyprinodon 
varieqatus), 
silverside 2 (Menidia 
sp) 
zebrafish (Danio 
rerio),  
Japanese medaka 
(Oryzias latipes), 
rainbow trout 
(Oncorhynchus 
mykiss),  
fathead minnow 
(Pimephales 
promelas),  
common carp 
(Cyprinus carpio), 
goldfish (Carassius 
auratus) 
bluegill (Lepomis 
macrochirus) 
tidewater silverside 2 
(Menidia peninsulae) 
herring2 (Clupea 
harengus) 
cod2 (Gadus morhua) 
sheepshead minnow2 
(Cyprinodon 
variegatus) 
rainbow trout 
(Oncorhynchus 
mykiss) is 
recommended species 
 
zebrafish (Danio 
rerio),  
Japanese medaka 
(Oryzias latipes) 
fathead minnow 
(Pimephales 
promelas) 
zebrafish (Danio 
rerio),  
fathead minnow 
(Pimephales 
promelas),  
common carp 
(Cyprinus carpio), 
Japanese medaka 
(Oryzias latipes), 
guppy (Poecilia 
reticulate),  
bluegill sunfish 
(Lepomis 
macrochirus), rainbow 
trout (Oncorhynchus 
mykiss); Three-spined 
stickleback 
(Gasterosteus 
aculeatus) 
 
 
Life stages 
covered 
fertilised eggs, 
embryos until 96h 
post-fertilisation 
Juvenile or adult fertilised eggs, 
embryo, sac-fry, 
larvae, juvenile fish 
fertilised eggs, 
embryo, sac-fry 
juvenile all adult 
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Guideline 
OECD TG 236 – Fish 
Embryo Acute 
Toxicity (FET) Test 
OECD TG 203 – 
Fish, Acute Toxicity 
Test 
OECD TG 210 – 
Fish, Early-life 
Stage Toxicity Test 
(as revised in 2013) 
OECD TG 212 – 
Fish, Short-term 
Toxicity Test on 
Embryo and Sac-
Fry Stages 
OECD TG 215 – 
Fish, Juvenile 
Growth Test 
USEPA OCSPP 
850.1500 – Fish 
life cycle test* 
OECD TG 305 – 
Bioaccumulation in 
Fish 
Number of 
animals 
(min) 
120  
(at least 20 fertilised 
eggs per 
concentration & 
control) 3 
42  
(at least 7-10 per 
concentrations & 
control) 
480  
(at least 
80/concentration & 
control) 
150  
(at least 30 fertilised 
eggs per 
concentration & 
control) 
Not defined; depends 
on the test design; at 
least two replicates 
per concentration 
Start with at least 4 x 
50 eggs per 
concentration 
305 I Aqueous 
exposure: 36 per 
concentration/control  
(4 fish per sampling 
point, total of 9 
sampling points) – 
305 II: minimised 
sampling – 16 per 
concentration/control 
305 III dietary 
exposure: at least 50-
120 fish (treatment 
group), 50-110 
control fish, and if 
needed 15 fish for 
lipid correction  
Concen-
trations 
At least 5 At least 5  At least 5 (or less 
when only NOEC 
needed; see limit test) 
At least 5 (or less 
with justification) 
At least 5 At least 5 At least 1 (to be 
justified 
Controls Water, and if needed 
solvent 
Water, and if needed 
solvent 
Water, and if needed 
solvent 
Water, and if needed 
solvent 
Water, and if needed 
solvent 
Water, and if needed 
solvent 
Water, and if needed 
solvent 
Duration 96 h 96 h 28-60 days (species 
dependant) 
Until embryos start 
feeding or onset of 
mortality due to 
starvation (for 
zebrafish TG states 8-
10 days) 
28 days At least 48 weeks At least 42 days (28 
days uptake; 14 days 
depuration) 
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Guideline 
OECD TG 236 – Fish 
Embryo Acute 
Toxicity (FET) Test 
OECD TG 203 – 
Fish, Acute Toxicity 
Test 
OECD TG 210 – 
Fish, Early-life 
Stage Toxicity Test 
(as revised in 2013) 
OECD TG 212 – 
Fish, Short-term 
Toxicity Test on 
Embryo and Sac-
Fry Stages 
OECD TG 215 – 
Fish, Juvenile 
Growth Test 
USEPA OCSPP 
850.1500 – Fish 
life cycle test* 
OECD TG 305 – 
Bioaccumulation in 
Fish 
Endpoint Lethal effects 
LC50 
Lethal effects 
LC50 
At all life stages: 
hatching success, 
abnormal appearance, 
abnormal behaviour, 
survival/mortality  
At the end of the test 
wet weight, length 
NOEC, LOEC (or ECx) 
for each observation 
Embryo/sac-fry stage: 
hatching success, 
abnormal appearance, 
abnormal behaviour, 
survival/mortality  
At the end of the test: 
weight, length 
Growth rate as ECx; 
NOEC, LOEC 
Hatching parameters, 
growth, survival, 
abnormalities, 
spawning parameters 
Bioconcentration 
factor (BCF) 
Effects in 
control 
Survival rate >90% Max 1 control fish can 
die  
Thresholds for 
hatching success, 
post-hatch survival 
(depending on the 
species) 
Thresholds for 
hatching success, 
post-hatch survival 
(depending on the 
species) 
< 10% mortality; 
> 50% weight gain 
Not given  
Limit test Limit test at single 
concentration >100 
mg/L; control(s); at 
least 20 fertilised 
eggs 
Limit test at single 
concentration >100 
mg/L; control(s); 7-10 
fish 
Limit test or extended 
limit test with fewer 
test concentrations; 
when empirical NOEC 
needed; 
Concentrations of the 
test chemical higher 
than the 96 hour LC50 
or 10 mg/L, whichever 
is the lower, need not 
be tested 
Limit test; 
concentrations above 
LC50 derived with TG 
203 or >100 mg/L 
not to be tested 
- - See above; reduced 
sampling schemes in 
305-II and 305-III 
 
* according to US EPA User's guide for conducting life-cycle chronic toxicity tests with fathead minnows (Pimephales promelas) 
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